Tapewire

NYSE · USD

QSR

Restaurant Brands International Inc.

Export transactions ↓
Tapewire entity
3102
SEC CIK
0001618756
Parsed reports
905

Last 12 months

Inside the activity.

0 purchase rows · 63 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 2025029
Jan 2026010
Feb 202609
Mar 202608
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantRestricted Share Units · Derivative 43.3759 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 6

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,788.1352

Underlying: Common Shares · 43.3759 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026.

Read SEC document
April 04, 2025 Filed Apr 8, 2025 21:51 UTC
Siddiqui Sami A.Chief Financial Officer
GrantRestricted Share Units · Derivative 21.8958 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000220 · wk-form4_1744149059.xml · derivative · entry 5

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417.0124

Underlying: Common Shares · 21.8958 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.

F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025.

Read SEC document
March 28, 2025 Filed Mar 4, 2025 18:05 UTC
KLEIN JEFFREY WPresident, Popeyes-US & Canada
GrantPerformance Share Units · Derivative 34,514 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000180 · wk-form4_1741129543.xml · derivative · entry 7

KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,514

Underlying: Common Shares · 34,514 shares

Expires 2028-03-15

F10 · derivative.exercise_price: The shares reported represent an award of performance base share units (the "2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
March 28, 2025 Filed Mar 4, 2025 23:05 UTC
Fulton DuncanChief Corporate Officer
GrantPerformance Share Units · Derivative 23,008 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000178 · wk-form4_1741129523.xml · derivative · entry 10

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,008

Underlying: Common Shares · 23,008 shares

Expires 2028-03-15

F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period ending February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 21:33 UTC
CURTIS THOMAS BENJAMINPres., BK US & CA
SaleCommon Shares 23,000 $68.38 $1,572,740.00
Disclosure

SEC source: 0001618756-25-000190 · wk-form4_1742592823.xml · nonDerivative · entry 1

CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,897.6316

F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $68.25 to $68.62 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.

F2 · balance_after: The number of shares reflects an addition of 90 shares that were inadvertently subtracted due to a typographical error made in the Reporting Person's Form 4 timely filed on February 26, 2024.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 21:34 UTC
Siddiqui Sami A.Chief Financial Officer
SaleCommon Shares 12,500 $68.12 $851,500.00
Disclosure

SEC source: 0001618756-25-000191 · wk-form4_1742592834.xml · nonDerivative · entry 3

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 235,228

F4 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $68.00 to $68.35 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.

F3 · ownership.nature: These shares are held by a revocable trust, of which the Reporting Person is the settlor and trustee for the benefit of the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 21:34 UTC
Siddiqui Sami A.Chief Financial Officer
GiftCommon Shares 81,639 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000191 · wk-form4_1742592834.xml · nonDerivative · entry 2

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 247,728

F1 · shares: The Reporting Person gifted these shares to his revocable trust in an exempt transaction pursuant to Rule 16b-5 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: On March 12, 2025, the Reporting Person timely filed a Form 4 to report the sale of an aggregate of 12,500 shares, which shares were sold by the revocable trust; however, due to an administrative error, the shares were reported as being sold from the Reporting Person's direct holdings. The number of shares held directly and indirectly through the revocable trust have been adjusted to reflect this correction.

F3 · ownership.nature: These shares are held by a revocable trust, of which the Reporting Person is the settlor and trustee for the benefit of the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 21:34 UTC
Siddiqui Sami A.Chief Financial Officer
GiftCommon Shares 81,639 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000191 · wk-form4_1742592834.xml · nonDerivative · entry 1

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,804.283

F1 · shares: The Reporting Person gifted these shares to his revocable trust in an exempt transaction pursuant to Rule 16b-5 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: On March 12, 2025, the Reporting Person timely filed a Form 4 to report the sale of an aggregate of 12,500 shares, which shares were sold by the revocable trust; however, due to an administrative error, the shares were reported as being sold from the Reporting Person's direct holdings. The number of shares held directly and indirectly through the revocable trust have been adjusted to reflect this correction.

Read SEC document
March 11, 2025 Filed Mar 12, 2025 21:18 UTC
Siddiqui Sami A.Chief Financial Officer
SaleCommon Shares 9,929 $68.00 $675,172.00
Disclosure

SEC source: 0001618756-25-000187 · wk-form4_1741814275.xml · nonDerivative · entry 2

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,943.283

Read SEC document
March 10, 2025 Filed Mar 12, 2025 21:18 UTC
Siddiqui Sami A.Chief Financial Officer
SaleCommon Shares 2,571 $70.15 $180,355.65
Disclosure

SEC source: 0001618756-25-000187 · wk-form4_1741814275.xml · nonDerivative · entry 1

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,872.283

F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $70.00 to $70.33 per shares. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Housman JeffreySee Remarks
GrantPerformance Share Units · Derivative 32,980 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000177 · wk-form4_1741129514.xml · derivative · entry 12

Housman Jeffrey · CIK 0001908101 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,980

Underlying: Common Shares · 32,980 shares

Expires 2028-03-15

F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Housman JeffreySee Remarks
GrantRestricted Share Units · Derivative 7,286 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000177 · wk-form4_1741129514.xml · derivative · entry 11

Housman Jeffrey · CIK 0001908101 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,286

Underlying: Common Shares · 7,286 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F11 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Housman JeffreySee Remarks
GrantCommon Shares 1,943 $65.19 $126,664.17
Disclosure

SEC source: 0001618756-25-000177 · wk-form4_1741129514.xml · nonDerivative · entry 1

Housman Jeffrey · CIK 0001908101 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,929.0864

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sale price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
SANTELMO THIAGO TPresident, International
GrantPerformance Share Units · Derivative 39,883 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000184 · wk-form4_1741129583.xml · derivative · entry 13

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,883

Underlying: Common Shares · 39,883 shares

Expires 2028-03-15

F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
SANTELMO THIAGO TPresident, International
GrantRestricted Share Units · Derivative 7,134 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000184 · wk-form4_1741129583.xml · derivative · entry 12

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,134

Underlying: Common Shares · 7,134 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F12 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
SANTELMO THIAGO TPresident, International
GrantCommon Shares 2,061 $65.19 $134,356.59
Disclosure

SEC source: 0001618756-25-000184 · wk-form4_1741129583.xml · nonDerivative · entry 1

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,406.1569

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 18:05 UTC
KLEIN JEFFREY WPresident, Popeyes-US & Canada
GrantRestricted Share Units · Derivative 6,979 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000180 · wk-form4_1741129543.xml · derivative · entry 6

KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,979

Underlying: Common Shares · 6,979 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F8 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 18:05 UTC
KLEIN JEFFREY WPresident, Popeyes-US & Canada
GrantCommon Shares 1,861 $65.19 $121,318.59
Disclosure

SEC source: 0001618756-25-000180 · wk-form4_1741129543.xml · nonDerivative · entry 1

KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,762.7801

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC GrantPerformance Share Units · Derivative 61,359 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000181 · wk-form4_1741129553.xml · derivative · entry 8

CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,359

Underlying: Common Shares · 61,359 shares

Expires 2028-03-15

F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC GrantRestricted Share Units · Derivative 9,384 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000181 · wk-form4_1741129553.xml · derivative · entry 7

CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,384

Underlying: Common Shares · 9,384 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F9 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC GrantCommon Shares 2,502 $65.19 $163,105.38
Disclosure

SEC source: 0001618756-25-000181 · wk-form4_1741129553.xml · nonDerivative · entry 1

CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,807.6316

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.29 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sales prices of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
Granat JillSee Remarks
GrantPerformance Share Units · Derivative 42,184 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000183 · wk-form4_1741129574.xml · derivative · entry 11

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,184

Underlying: Common Shares · 42,184 shares

Expires 2028-03-15

F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
Granat JillSee Remarks
GrantRestricted Share Units · Derivative 9,796 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000183 · wk-form4_1741129574.xml · derivative · entry 10

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,796

Underlying: Common Shares · 9,796 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F11 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of her 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, she will forfeit all of the 2025 RSUs that have not yet vested.

F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
Granat JillSee Remarks
GrantCommon Shares 2,612 $65.19 $170,276.28
Disclosure

SEC source: 0001618756-25-000183 · wk-form4_1741129574.xml · nonDerivative · entry 1

Granat Jill · CIK 0001552022 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 455,614.6543

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of her 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sale price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC GrantPerformance Share Units · Derivative 16,873 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000185 · wk-form4_1741129594.xml · derivative · entry 11

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,873

Underlying: Common Shares · 16,873 shares

Expires 2028-03-15

F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28. 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance period.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC GrantRestricted Share Units · Derivative 4,413 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000185 · wk-form4_1741129594.xml · derivative · entry 10

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,413

Underlying: Common Shares · 4,413 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share.

F11 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of her 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.0 for senior vice presidents and above. If the Reporting Person sells any of the Investment Shares, she will forfeit all of the 2025 RSUs that have not yet vested.

F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC GrantCommon Shares 1,323 $65.19 $86,246.37
Disclosure

SEC source: 0001618756-25-000185 · wk-form4_1741129594.xml · nonDerivative · entry 1

Friesner Jacqueline · CIK 0001552051 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,897.091

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of her 2024 net bonus to purchase common shares at a purchase price of $65.19 per share.

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Kobza JoshuaChief Executive Officer
GrantPerformance Share Units · Derivative 153,397 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000176 · wk-form4_1741129503.xml · derivative · entry 10

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,397

Underlying: Common Shares · 153,397 shares

Expires 2028-03-15

F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Kobza JoshuaChief Executive Officer
GrantRestricted Share Units · Derivative 19,527 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000176 · wk-form4_1741129503.xml · derivative · entry 9

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,527

Underlying: Common Shares · 19,527 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F11 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Kobza JoshuaChief Executive Officer
GrantCommon Shares 5,207 $65.19 $339,444.33
Disclosure

SEC source: 0001618756-25-000176 · wk-form4_1741129503.xml · nonDerivative · entry 1

Kobza Joshua · CIK 0001574771 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 966,501.5173

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in the case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Schwan AxelPres., Tim Hortons Americas
GrantPerformance Share Units · Derivative 61,359 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000179 · wk-form4_1741129533.xml · derivative · entry 11

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,359

Underlying: Common Shares · 61,359 shares

Expires 2028-03-15

F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Schwan AxelPres., Tim Hortons Americas
GrantRestricted Share Units · Derivative 12,082 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000179 · wk-form4_1741129533.xml · derivative · entry 10

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,082

Underlying: Common Shares · 12,082 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F9 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Schwan AxelPres., Tim Hortons Americas
GrantCommon Shares 2,685 $65.19 $175,035.15
Disclosure

SEC source: 0001618756-25-000179 · wk-form4_1741129533.xml · nonDerivative · entry 1

SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,760.389

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
Siddiqui Sami A.Chief Financial Officer
GrantPerformance Share Units · Derivative 69,028 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000182 · wk-form4_1741129563.xml · derivative · entry 11

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,028

Underlying: Common Shares · 69,028 shares

Expires 2028-03-15

F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
Siddiqui Sami A.Chief Financial Officer
GrantRestricted Share Units · Derivative 10,040 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000182 · wk-form4_1741129563.xml · derivative · entry 10

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,040

Underlying: Common Shares · 10,040 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F11 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $65.19 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:06 UTC
Siddiqui Sami A.Chief Financial Officer
GrantCommon Shares 2,677 $65.19 $174,513.63
Disclosure

SEC source: 0001618756-25-000182 · wk-form4_1741129563.xml · nonDerivative · entry 1

Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,443.283

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of $65.19 per share ("Investment Shares").

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Fulton DuncanChief Corporate Officer
GrantRestricted Share Units · Derivative 6,269 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000178 · wk-form4_1741129523.xml · derivative · entry 9

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,269

Underlying: Common Shares · 6,269 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share.

F12 · shares: The Issuer granted the 2025 restricted share units ("2025 RSUs") to the Reporting Person pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Plan. The Reporting Person elected to use 50% of his 2024 net bonus to purchase Investment Shares and received a matching grant of 2025 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of CAD$94.12 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2025 RSUs that have not yet vested.

F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Fulton DuncanChief Corporate Officer
GrantCommon Shares 1,393 $65.26 $90,907.18
Disclosure

SEC source: 0001618756-25-000178 · wk-form4_1741129523.xml · nonDerivative · entry 1

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,215.1586

F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2024 Bonus Swap Program under its 2023 Omnibus Incentive Plan ("2023 Plan"). The Reporting Person elected to use 50% of his 2024 net bonus to purchase common shares at a purchase price of CAD$94.12 per share ("Investment Shares"). The purchase price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on February 27, 2025.

F2 · price: Pursuant to the Issuer's 2023 Plan, the purchase price of the Investment Shares is calculated based on, the last sales prices of the common share of the Issuer on the Toronto Stock Exchange on the trading day immediately preceding the grant date, in this case February 27, 2025.

Read SEC document
February 27, 2025 Filed Feb 27, 2025 22:26 UTC
Fulton DuncanChief Corporate Officer
SaleCommon Shares 27,500 $64.66 $1,778,150.00
Disclosure

SEC source: 0001618756-25-000139 · wk-form4_1740695163.xml · nonDerivative · entry 3

Fulton Duncan · CIK 0001908102 · Chief Corporate Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,822.1586

F4 · price: Represents the weighted average price of the shares sold. The reported shares were sold at prices ranging from USD $64.28 to USD $65.15 per share. The sale price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on the sale date. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Housman JeffreySee Remarks
Exercise / conversionPerformance Share Units · Derivative 27,317.1055 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000145 · wk-form4_1740695225.xml · derivative · entry 8

Housman Jeffrey · CIK 0001908101 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 27,317.1055 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025, which has been selected as the vesting date of the grant. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Housman JeffreySee Remarks
SaleCommon Shares 14,593.3539 $64.38 $939,520.12
Disclosure

SEC source: 0001618756-25-000145 · wk-form4_1740695225.xml · nonDerivative · entry 2

Housman Jeffrey · CIK 0001908101 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,986.0864

F2 · shares: Represents shares sold to cover withholding taxes on the settlement of the vesting of the Reporting Person's performance share units.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Housman JeffreySee Remarks
Exercise / conversionCommon Shares 37,086.0325 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000145 · wk-form4_1740695225.xml · nonDerivative · entry 1

Housman Jeffrey · CIK 0001908101 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,579.4403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The 2022 PBRSUs vested at 135.76% of target based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
KLEIN JEFFREY WPresident, Popeyes-US & Canada
Exercise / conversionPerformance Share Units · Derivative 10,967.2015 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000140 · wk-form4_1740695173.xml · derivative · entry 4

KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 10,967.2015 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The shares reported represent an award of performance base share units (the "2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning on January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
KLEIN JEFFREY WPresident, Popeyes-US & Canada
SaleCommon Shares 5,858.9572 $64.38 $377,199.66
Disclosure

SEC source: 0001618756-25-000140 · wk-form4_1740695173.xml · nonDerivative · entry 2

KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,901.7801

F2 · shares: Represents shares sold to cover withholding taxes on the settlement of the vesting of the Reporting Person's performance share units.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
KLEIN JEFFREY WPresident, Popeyes-US & Canada
Exercise / conversionCommon Shares 14,889.3448 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000140 · wk-form4_1740695173.xml · nonDerivative · entry 1

KLEIN JEFFREY W · CIK 0002016193 · President, Popeyes-US & Canada

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,760.7373

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The 2022 PBRSUs vested at 135.76% of target based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
SANTELMO THIAGO TPresident, International
Exercise / conversionPerformance Share Units · Derivative 21,853.2457 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000143 · wk-form4_1740695204.xml · derivative · entry 10

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 21,853.2457 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2021 and ending on December 31, 2024 and to the extent earned will vest on February 25, 2025, which has been selected as the vesting date of the grant. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
SANTELMO THIAGO TPresident, International
SaleCommon Shares 10,859.0932 $64.38 $699,108.42
Disclosure

SEC source: 0001618756-25-000143 · wk-form4_1740695204.xml · nonDerivative · entry 2

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,345.1569

F2 · shares: Represents shares sold to cover withholding taxes on the settlement of the vesting of the Reporting Person's performance share units.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
SANTELMO THIAGO TPresident, International
Exercise / conversionCommon Shares 29,668.6821 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000143 · wk-form4_1740695204.xml · nonDerivative · entry 1

SANTELMO THIAGO T · CIK 0002015936 · President, International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,204.2501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The 2022 PBRSUs vested at 135.76% of target based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:25 UTC Exercise / conversionPerformance Share Units · Derivative 43,707.5882 $0.00 $0.00
Disclosure

SEC source: 0001618756-25-000138 · wk-form4_1740695152.xml · derivative · entry 4

CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 43,707.5882 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2022 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:25 UTC SaleCommon Shares 23,349.5136 $64.38 $1,503,241.69
Disclosure

SEC source: 0001618756-25-000138 · wk-form4_1740695152.xml · nonDerivative · entry 2

CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,305.6316

F2 · shares: Represents shares sold to cover withholding taxes on the settlement of the vesting of the Reporting Person's performance share units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.